Page last updated: 2024-08-24

triazoles and ssya10-001

triazoles has been researched along with ssya10-001 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Adedeji, AO; Calcaterra, NE; DeDiego, ML; Enjuanes, L; Sarafianos, SG; Singh, K; Weiss, S	1
Adedeji, AO; Coleman, CM; Elliott, R; Frieman, MB; Kassim, A; Sarafianos, SG; Singh, K; Weiss, SR	1
Gallazzi, F; Lorson, CL; Quinn, TP; Singh, K; Sönnerborg, A; Spratt, AN	1

Reviews

1 review(s) available for triazoles and ssya10-001

Article	Year
Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents. Expert opinion on therapeutic patents, 2021, Volume: 31, Issue:4 Topics: Antiviral Agents; COVID-19 Drug Treatment; Drug Development; Humans; Methyltransferases; Patents as Topic; RNA Helicases; SARS-CoV-2; Triazoles; Viral Nonstructural Proteins	2021

Other Studies

2 other study(ies) available for triazoles and ssya10-001

Article	Year
Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9 Topics: Antiviral Agents; Cell Survival; DNA Helicases; Escherichia coli; Fluorescence Resonance Energy Transfer; HEK293 Cells; Humans; Inhibitory Concentration 50; Kinetics; Nucleic Acid Conformation; Recombinant Proteins; RNA, Double-Stranded; RNA, Viral; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Small Molecule Libraries; Triazoles; Viral Proteins; Virus Replication	2012
Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8 Topics: Amino Acid Sequence; Animals; Antiviral Agents; Binding Sites; Cell Line; Chlorocebus aethiops; DNA Helicases; Dose-Response Relationship, Drug; Fibroblasts; Humans; Inhibitory Concentration 50; Mice; Middle East Respiratory Syndrome Coronavirus; Molecular Docking Simulation; Molecular Sequence Data; Murine hepatitis virus; Protein Binding; Sequence Alignment; Sequence Homology, Amino Acid; Severe acute respiratory syndrome-related coronavirus; Triazoles; Vero Cells; Viral Proteins; Virus Replication	2014

Article

Year

Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.

Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9

Topics: Antiviral Agents; Cell Survival; DNA Helicases; Escherichia coli; Fluorescence Resonance Energy Transfer; HEK293 Cells; Humans; Inhibitory Concentration 50; Kinetics; Nucleic Acid Conformation; Recombinant Proteins; RNA, Double-Stranded; RNA, Viral; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Small Molecule Libraries; Triazoles; Viral Proteins; Virus Replication

2012

Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses.

Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8

Topics: Amino Acid Sequence; Animals; Antiviral Agents; Binding Sites; Cell Line; Chlorocebus aethiops; DNA Helicases; Dose-Response Relationship, Drug; Fibroblasts; Humans; Inhibitory Concentration 50; Mice; Middle East Respiratory Syndrome Coronavirus; Molecular Docking Simulation; Molecular Sequence Data; Murine hepatitis virus; Protein Binding; Sequence Alignment; Sequence Homology, Amino Acid; Severe acute respiratory syndrome-related coronavirus; Triazoles; Vero Cells; Viral Proteins; Virus Replication

2014